• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索骨肉瘤的基因组不稳定性雷区,以更好地理解非编码RNA的影响。

Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.

作者信息

Fatema Kaniz, Larson Zachary, Barrott Jared

机构信息

Biomedical and Pharmaceutical Science, Idaho State University, Pocatello, 83209, USA.

出版信息

Biocell. 2022 Jun 13;46(10):2177-2193. doi: 10.32604/biocell.2022.020141.

DOI:10.32604/biocell.2022.020141
PMID:35755302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9224338/
Abstract

Osteosarcoma is one of the most genomically complex cancers and as result, it has been difficult to assign genomic aberrations that contribute to disease progression and patient outcome consistently across samples. One potential source for correlating osteosarcoma and genomic biomarkers is within the non-coding regions of RNA that are differentially expressed. However, it is unsurprising that a cancer classification that is fraught with genomic instability is likely to have numerous studies correlating non-coding RNA expression and function have been published on the subject. This review undertakes the formidable task of evaluating the published literature of noncoding RNAs in osteosarcoma. This is not the first review on this topic and will certainly not be the last. The review is organized with an introduction into osteosarcoma and the epigenetic control of gene expression before reviewing the molecular function and expression of long non-coding RNAs, circular RNAs, and short non-coding RNAs such as microRNAs, piwi RNAs, and short-interfering RNAs. The review concludes with a review of the literature and how the biology of non-coding RNAs can be used therapeutically to treat cancers, especially osteosarcoma. We conclude that non-coding RNA expression and function in osteosarcoma is equally complex to understanding the expression differences and function of coding RNA and proteins; however, with the added lens of both coding and non-coding genomic sequence, researchers can begin to identify the patterns that consistently associate with aggressive osteosarcoma.

摘要

骨肉瘤是基因组最复杂的癌症之一,因此,很难在不同样本中一致地确定导致疾病进展和患者预后的基因组畸变。骨肉瘤与基因组生物标志物相关的一个潜在来源在于差异表达的RNA非编码区域。然而,对于一个充满基因组不稳定性的癌症分类而言,有大量关于非编码RNA表达和功能相关性的研究发表也就不足为奇了。本综述承担了评估骨肉瘤中已发表的非编码RNA文献这一艰巨任务。这不是关于该主题的第一篇综述,当然也不会是最后一篇。该综述在回顾长链非编码RNA、环状RNA以及微小RNA、piwi RNA和短干扰RNA等短链非编码RNA的分子功能和表达之前,先对骨肉瘤以及基因表达的表观遗传调控进行了介绍。综述最后回顾了相关文献,以及非编码RNA的生物学特性如何用于癌症治疗,尤其是骨肉瘤的治疗。我们得出结论,骨肉瘤中非编码RNA的表达和功能与理解编码RNA和蛋白质的表达差异及功能同样复杂;然而,通过编码和非编码基因组序列这一额外视角,研究人员能够开始识别与侵袭性骨肉瘤始终相关的模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/ebba4fe9f5e4/nihms-1815810-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/429b51f24a82/nihms-1815810-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/d25e7a3d325d/nihms-1815810-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/ebba4fe9f5e4/nihms-1815810-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/429b51f24a82/nihms-1815810-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/d25e7a3d325d/nihms-1815810-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5d8/9224338/ebba4fe9f5e4/nihms-1815810-f0003.jpg

相似文献

1
Navigating the genomic instability mine field of osteosarcoma to better understand implications of non-coding RNAs.探索骨肉瘤的基因组不稳定性雷区,以更好地理解非编码RNA的影响。
Biocell. 2022 Jun 13;46(10):2177-2193. doi: 10.32604/biocell.2022.020141.
2
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.位于14q32的一个印记非编码基因组簇在多个独立数据集中定义了骨肉瘤中具有临床相关性的分子亚型。
J Hematol Oncol. 2017 May 15;10(1):107. doi: 10.1186/s13045-017-0465-4.
3
Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.药物诱导的 microRNAs 和长非编码 RNA 的修饰和调控,用于未来治疗多形性胶质母细胞瘤。
Gene. 2020 Jan 10;723:144126. doi: 10.1016/j.gene.2019.144126. Epub 2019 Oct 4.
4
The role of non‑coding RNAs in the regulation, diagnosis, prognosis and treatment of osteosarcoma (Review).非编码RNA在骨肉瘤的调控、诊断、预后及治疗中的作用(综述)
Int J Oncol. 2021 Sep;59(3). doi: 10.3892/ijo.2021.5249. Epub 2021 Jul 23.
5
Development and analysis of long non-coding RNA-associated competing endogenous RNA network for osteosarcoma metastasis.长非编码 RNA 相关竞争性内源 RNA 网络在骨肉瘤转移中的构建和分析。
Hereditas. 2021 Feb 16;158(1):9. doi: 10.1186/s41065-021-00174-0.
6
Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.非编码环状 RNA 和 microRNA 在心血管疾病发病机制中的意义。
J Med Genet. 2018 Nov;55(11):713-720. doi: 10.1136/jmedgenet-2018-105387. Epub 2018 Sep 3.
7
Noncoding RNAs in osteosarcoma: Implications for drug resistance.非编码 RNA 在骨肉瘤中的作用:与耐药性的关系。
Cancer Lett. 2021 Apr 28;504:91-103. doi: 10.1016/j.canlet.2021.02.007. Epub 2021 Feb 12.
8
Comprehensive Analysis of lncRNA-miRNA- mRNA Network Ascertains Prognostic Factors in Patients with Colon Cancer.综合分析 lncRNA-miRNA-mRNA 网络确定结肠癌患者的预后因素。
Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819853237. doi: 10.1177/1533033819853237.
9
Non-coding RNA in cancer.癌症中的非编码 RNA
Essays Biochem. 2021 Oct 27;65(4):625-639. doi: 10.1042/EBC20200032.
10
Emerging roles of non-coding RNAs in the pathogenesis, diagnosis and prognosis of osteosarcoma.非编码 RNA 在骨肉瘤发病机制、诊断和预后中的新兴作用。
Invest New Drugs. 2018 Dec;36(6):1116-1132. doi: 10.1007/s10637-018-0624-7. Epub 2018 Aug 6.

引用本文的文献

1
Deregulation mechanisms and therapeutic opportunities of p53-responsive microRNAs in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中p53反应性微小RNA的去调控机制及治疗机会
PeerJ. 2025 Jan 7;13:e18661. doi: 10.7717/peerj.18661. eCollection 2025.
2
Loss Enhances Disease Progression in a Murine Model of Osteosarcoma.在骨肉瘤小鼠模型中,损耗会加速疾病进展。
Cancers (Basel). 2024 Jul 31;16(15):2725. doi: 10.3390/cancers16152725.
3
Targeting HOXA11-AS to mitigate prostate cancer via the glycolytic metabolism: In vitro and in vivo.

本文引用的文献

1
MicroRNA-133b Inhibits nTumor Cell Proliferation, Migration and Invasion by Targeting SUMO1 in Endometrial Carcinoma.微小 RNA-133b 通过靶向 SUMO1 抑制子宫内膜癌 n 肿瘤细胞增殖、迁移和侵袭。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211065241. doi: 10.1177/15330338211065241.
2
Circling back to epigenetic regulation in osteosarcoma: Comment on 'Hsa_circ_0088212-mediated miR-520h/APOA1 axis inhibits the osteosarcoma progression' by ' Hao Peng'.回到骨肉瘤中的表观遗传调控:对彭浩的《Hsa_circ_0088212介导的miR-520h/APOA1轴抑制骨肉瘤进展》的评论
Transl Oncol. 2022 Jan;15(1):101271. doi: 10.1016/j.tranon.2021.101271. Epub 2021 Nov 18.
3
靶向 HOXA11-AS 减轻前列腺癌的糖酵解代谢:体外和体内研究。
J Cell Mol Med. 2024 Apr;28(8):e18227. doi: 10.1111/jcmm.18227.
Hsa_circ_0088212-mediated miR-520 h/APOA1 axis inhibits osteosarcoma progression.
人源环状RNA hsa_circ_0088212介导的miR-520h/载脂蛋白A1轴抑制骨肉瘤进展。
Transl Oncol. 2021 Dec;14(12):101219. doi: 10.1016/j.tranon.2021.101219. Epub 2021 Sep 21.
4
The circular RNA circCRIM1 inhibits osteosarcoma progression through sponging miR-513.环状RNA circCRIM1通过吸附miR-513抑制骨肉瘤进展。
Mamm Genome. 2021 Dec;32(6):495-502. doi: 10.1007/s00335-021-09903-2. Epub 2021 Sep 3.
5
Role of MicroRNAs in Human Osteosarcoma: Future Perspectives.微小RNA在人类骨肉瘤中的作用:未来展望。
Biomedicines. 2021 Apr 23;9(5):463. doi: 10.3390/biomedicines9050463.
6
Non-coding RNA in cancer.癌症中的非编码 RNA
Essays Biochem. 2021 Oct 27;65(4):625-639. doi: 10.1042/EBC20200032.
7
Epigenetic Regulation of MicroRNA Clusters and Families during Tumor Development.肿瘤发生过程中MicroRNA簇和家族的表观遗传调控
Cancers (Basel). 2021 Mar 16;13(6):1333. doi: 10.3390/cancers13061333.
8
LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.长链非编码 RNA FOXD2-AS1 敲低通过抑制 miR-143 的表达抑制人骨肉瘤细胞对顺铂的耐药性。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):678-686. doi: 10.26355/eurrev_202101_24629.
9
The cross-talk between signaling pathways, noncoding RNAs and DNA damage response: Emerging players in cancer progression.信号通路、非编码 RNA 与 DNA 损伤反应的串扰:癌症进展中的新兴参与者。
DNA Repair (Amst). 2021 Feb;98:103036. doi: 10.1016/j.dnarep.2020.103036. Epub 2021 Jan 7.
10
circHIPK3 promotes proliferation and migration and invasion via regulation of miR‑637/HDAC4 signaling in osteosarcoma cells.circHIPK3 通过调控 miR-637/HDAC4 信号通路促进骨肉瘤细胞的增殖、迁移和侵袭。
Oncol Rep. 2021 Jan;45(1):169-179. doi: 10.3892/or.2020.7833. Epub 2020 Nov 3.